YBX1 and head and neck squamous cell carcinoma: Our results indicate that, grade 2 HNSCC patients (Figure 4B) with low YB-1 protein expression levels have a 5-year DSS rate (74%, n=29) similar to the G1 patient subgroup (83%, n=23) without YB-1 stratification.